Elango Subramoniapillai

Herston, QLD, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Authors' reply to 'Comments on dose-dependent impairment of brain functional and microstructural connectivity during leukaemia chemotherapy'.

Authors' reply to 'Comments on dose-dependent impairment of brain functional and microstructural connectivity during leukaemia chemotherapy'.

Journal: British journal of haematology

Published: April 16, 2026

Dose-dependent impairment of brain functional and microstructural connectivity during leukaemia chemotherapy.

Dose-dependent impairment of brain functional and microstructural connectivity during leukaemia chemotherapy.

Journal: British journal of haematology

Published: November 14, 2025

Granulocyte transfusion supportive care for prolonged cytopenias post CD19 CAR T cell therapy.

Granulocyte transfusion supportive care for prolonged cytopenias post CD19 CAR T cell therapy.

Journal: Transfusion

Published: November 21, 2023

Quantifying skin cancer risk following allogeneic haematopoietic cell transplant in Queensland, Australia.

Quantifying skin cancer risk following allogeneic haematopoietic cell transplant in Queensland, Australia.

Journal: Bone marrow transplantation

Published: August 02, 2023

High incidence of resistant breakthrough invasive fungal infections (IFD) in patients treated for acute gastrointestinal graft-versus-host disease (GI GVHD) following allogeneic haematopoietic cell transplantation.

High incidence of resistant breakthrough invasive fungal infections (IFD) in patients treated for acute gastrointestinal graft-versus-host disease (GI GVHD) following allogeneic haematopoietic cell transplantation.

Journal: Bone marrow transplantation

Published: February 24, 2022

Management and Outcomes of Diffuse Large B-cell Lymphoma Post-transplant Lymphoproliferative Disorder in the Era of PET and Rituximab: A Multicenter Study From the Australasian Lymphoma Alliance.

Management and Outcomes of Diffuse Large B-cell Lymphoma Post-transplant Lymphoproliferative Disorder in the Era of PET and Rituximab: A Multicenter Study From the Australasian Lymphoma Alliance.

Journal: HemaSphere

Published: May 05, 2021

A phase 3 double-blind study of the addition of tocilizumab vs placebo to cyclosporin/methotrexate GVHD prophylaxis.

A phase 3 double-blind study of the addition of tocilizumab vs placebo to cyclosporin/methotrexate GVHD prophylaxis.

Journal: Blood

Published: September 08, 2020

Pegylated interferon-2α invokes graft-versus-leukemia effects in patients relapsing after allogeneic stem cell transplantation.

Pegylated interferon-2α invokes graft-versus-leukemia effects in patients relapsing after allogeneic stem cell transplantation.

Journal: Blood advances

Published: May 15, 2019

Mismatched unrelated donor allogeneic stem cell transplant for high risk haematological malignancy: A single centre experience.

Mismatched unrelated donor allogeneic stem cell transplant for high risk haematological malignancy: A single centre experience.

Journal: Blood cancer journal

Published: June 19, 2017

Successful use of oseltamivir prophylaxis in managing a nosocomial outbreak of influenza A in a hematology and allogeneic stem cell transplant unit.

Successful use of oseltamivir prophylaxis in managing a nosocomial outbreak of influenza A in a hematology and allogeneic stem cell transplant unit.

Journal: Asia-Pacific journal of clinical oncology

Published: November 12, 2015

Addition of interleukin-6 inhibition with tocilizumab to standard graft-versus-host disease prophylaxis after allogeneic stem-cell transplantation: a phase 1/2 trial.

Addition of interleukin-6 inhibition with tocilizumab to standard graft-versus-host disease prophylaxis after allogeneic stem-cell transplantation: a phase 1/2 trial.

Journal: The Lancet. Oncology

Published: December 03, 2014

Showing 1-11 of 11

Last Updated: 09/26/2026